Development and External Validation of Prognostic Model for 2-Year Survival of Non–Small-Cell Lung Cancer Patients Treated With Chemoradiotherapy
International Journal of Radiation Oncology*Biology*PhysicsPublished 26 December 2008
Cary Oberije, Shipeng Yu, Dirk De Ruysscher, Sabine Meersschout, Karen Van Beek, Yolande Lievens
Citations117
SJR quartileQ1
SJR score2.06
SNIP1.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The multivariate model performed very well and was able to accurately predict the 2-year survival of NSCLC patients treated with chemoradiotherapy, and could support clinicians in the treatment decision-making process.
Abstract
The multivariate model performed very well and was able to accurately predict the 2-year survival of NSCLC patients treated with chemoradiotherapy. The model could support clinicians in the treatment decision-making process.
Keywords
Medicine
Cambridge University Press eBooksAn Introduction to Support Vector Machines and Other Kernel-based Learning Methods
13,883 Citations2000Nello Cristianini, John Shawe‐Taylor
Statistics in MedicineMULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS
9,798 Citations1996Frank E. Harrell, Kerry L. Lee +1 more
The MIT Press eBooksAdvances in Large-Margin Classifiers
1,870 Citations2000
This book provides an overview of recent developments in large margin classifiers, examines connections with other methods, and identifies strengths and weaknesses of the method, as well as directions for future research.
Journal of Clinical OncologyAmerican Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
1,426 Citations2003David G. Pfister, David H. Johnson +9 more
The MIT Press eBooksProbabilities for SV Machines
1,015 Citations2000John C. Platt
This chapter contains sections titled: Introduction, Fitting a Sigmoid After the SVM, Empirical Tests, Conclusions, Appendix: Pseudo-code for the Sigmoids Training.
Journal of Clinical EpidemiologyInternal and external validation of predictive models: A simulation study of bias and precision in small samples
578 Citations2003Ewout W. Steyerberg, Sacha E. Bleeker +3 more
Bootstrapping for internal validation gives reasonably valid estimates of the expected optimism in predictive performance provided that any selection of predictors is taken into account, and should be used for external validation.
CHEST JournalPrognostic Factors in Non-small Cell Lung Cancer
571 Citations2002Michael Brundage, Diane Davies +1 more
While the breadth of prognostic factors studied in the literature is extensive, the scope of factors evaluated in individual studies is inappropriately narrow and individual studies are typically statistically underpowered and remarkably heterogeneous with regard to their conclusions.
International Journal of Radiation Oncology*Biology*PhysicsA challenge to traditional radiation oncology
290 Citations2004Jack F. Fowler, Wolfgang A. Tomé +2 more
Investigating and comparing the biologically effective doses, equivalent doses in 2-Gy fractions, log tumor cells killed, and late effects that can be estimated for the large fractions in short overall times that are now being delivered in various clinically used schedules in several countries for the treatment of cancer in human lungs, liver, and kidney finds such large doses can apparently be given, with suitable precautions and experience.
The OncologistThe Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung Cancer
239 Citations2004Liesbet Schrevens, Natalie Lorent +2 more
International Journal of Radiation Oncology*Biology*PhysicsGross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma
233 Citations2002Jeffrey D. Bradley, Nantaken Ieumwananonthachai +5 more
GTV as determined by CT and 3D-CRT planning is highly prognostic for overall and cause-specific survival and local tumor control and may be important in stratification of patients in prospective therapy trials.
Radiotherapy and OncologyLiterature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer
224 Citations2004Suresh Senan, Dirk De Ruysscher +3 more
Although most of the recommended techniques have yet to be evaluated in multicenter clinical trials, their use in high-dose radiotherapy to the thorax appears to be rational on the basis of current evidence.
International Journal of Radiation Oncology*Biology*PhysicsSelective mediastinal node irradiation based on FDG-PET scan data in patients with non–small-cell lung cancer: A prospective clinical study
214 Citations2005Dirk De Ruysscher, S. Wanders +16 more
Selective mediastinal node irradiation based on FDG-PET scan data in patients with NSCLC results in low isolated nodal failure rates, and radiation dose escalation up to 64.8 Gy in 36 fractions over 24 days is feasible.
International Journal of Radiation Oncology*Biology*PhysicsRecursive partitioning analysis of 1999 radiation therapy oncology group (RTOG) patients with locally-advanced non–small-cell lung cancer (LA-NSCLC): Identification of five groups with different survival
201 Citations2000Maria Werner‐Wasik, Charles Scott +7 more
Cisplatinum-based CT improves survival, for excellent prognosis of LA-NSCLC patients, over RT alone, and the presence of a malignant pleural effusion is a major negative prognostic factor for survival.
European Journal of CancerThe maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1α and GLUT-1 in non-small cell lung cancer
194 Citations2007Angela van Baardwijk, Christophe Dooms +11 more
This study supports preclinical data that hypoxia is associated with a higher uptake of FDG and helps clarify the relationship between standardised uptake value (SUV) and proliferation-related markers and glucose transporters in non-small cell lung cancer.
International Journal of Radiation Oncology*Biology*PhysicsComorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies
192 Citations2002S. Firat, Roger W. Byhardt +1 more
Multivariate analysis with clinical stage, KPS, and comorbidity (severity index) of all patients showed that a KPS 2 were independently associated with inferior OS; clinical tumor stage was not found to be an independent prognostic factor.
The Annals of Thoracic SurgerySurvival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases
175 Citations1997Johan Vansteenkiste, Paul R. De Leyn +5 more
In clinical NO or N1 cancer, complete resection resulted in reasonable survival prospects, and in patients with N2 disease discovered at mediastinoscopy, surgical treatment was only worthwhile in case of minimal N2.
CHEST JournalDiagnosis and Management of Lung Cancer Executive Summary
166 Citations2007W. Michael Alberts
BMJChemotherapy for non-small cell lung cancer
151 Citations1995David P. Carbone, J. D Minna
A meta-analysis of updated data from 9387 patients participating in 52 randomised clinical trials comparing chemotherapy with no chemotherapy suggests that the benefits of chemotherapy of non-small cell lung cancer are small.
Clinical Cancer ResearchFluorodeoxyglucose Uptake of Primary Non-Small Cell Lung Cancer at Positron Emission Tomography: New Contrary Data on Prognostic Role
137 Citations2007Hubert Vesselle, Joseph D. Freeman +8 more
As expected, tumor stage is prognostic in NSCLC, but tumor FDG uptake does not provide additional prognostic information, and SUV definitions based on lean body mass, body surface area, and plasma glucose correction yielded identical results.
International Journal of Radiation Oncology*Biology*PhysicsTumor Volume Combined With Number of Positive Lymph Node Stations Is a More Important Prognostic Factor Than TNM Stage for Survival of Non–Small-Cell Lung Cancer Patients Treated With (Chemo)radiotherapy
125 Citations2007Cary Oberije, Dirk De Ruysscher +11 more
Investigation of the prognostic value of tumor volume and N status, assessed by using fluorodeoxyglucose-positron emission tomography (PET), showed that number of positive lymph node stations (PLNSs), as well as N stage on PET, was associated significantly with survival.
The Lancet Oncology4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index
125 Citations2006F Blanchon, M Grivaux +5 more
This prognostic index, incorporating personal, tumour, and functional information would be helpful in guiding patient management, resource use, and the design of clinical trials.
International Journal of Radiation Oncology*Biology*PhysicsIncreasing Tumor Volume is Predictive of Poor Overall and Progression-Free Survival: Secondary Analysis of the Radiation Therapy Oncology Group 93-11 Phase I-II Radiation Dose-Escalation Study in Patients with Inoperable Non–Small-Cell Lung Cancer
113 Citations2007Maria Werner‐Wasik, Ruth Swann +5 more
Patients with non-small-cell lung cancer in the RTOG 93-11 trial received radiation doses of 70.9, 77.4, 83.8, or 90.3 Gy and the effect of the gross tumor volume (GTV) on the outcome was investigated.
CancerA prognostic model for advanced stage nonsmall cell lung cancer
108 Citations2006Sumithra J. Mandrekar, Steven E. Schild +10 more
A pooled analysis was performed to examine the impact of pretreatment factors on overall survival (OS) and time to progression (TTP) in patients with advanced‐stage nonsmall cell lung cancer (NSCLC) and to construct a prediction equation for OS using pret treatment factors.
International Journal of Radiation Oncology*Biology*PhysicsPrognostic factors for survival in stage III non–small-cell lung cancer treated with definitive radiation therapy: Impact of tumor volume
108 Citations2005Kiyoshi Basaki, Yoshinao Abe +4 more
The primary tumor volume as well as TTV is a significant prognostic factor on survival in patients with Stage III NSCLC treated with RT and should be recorded in clinical results when the survivals are compared among clinical studies.
International Journal of Radiation Oncology*Biology*PhysicsFailure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC)
80 Citations1998Ritsuko Komaki, Charles Scott +7 more
It is suggested that physiologic compromise from the intrathoracic disease in Class IV patients is sufficient to cause death before specific sites of failure became evident, and clinical investigations using treatments directed at specific Sites of failure could lead to improved outcome for Class I, II and, possibly, Class III patients.
Journal of Thoracic and Cardiovascular SurgeryLong-term survival after non–small cell lung cancer surgery: Development and validation of a prognostic model with a preoperative and postoperative mode
73 Citations2006Özcan Birim, A. Pieter Kappetein +6 more
The prognostic model, particularly the postoperative mode, successfully estimates long-term survival of individual patients and could help clinicians in clinical decision-making and treatment tailoring.
Radiotherapy and OncologyThe integration of PET-CT scans from different hospitals into radiotherapy treatment planning
70 Citations2008Michel Öllers, Geert Bosmans +7 more
Whenever this goal has been achieved automated SUV delineation based on a S/B ratio using PET-CT images from different institutions can reliably be performed using individually determined threshold curves.
Lung CancerFDG-PET maximum standardised uptake value is associated with variation in survival: Analysis of 498 lung cancer patients
68 Citations2006Andrew Davies, Carol Tan +5 more
From the analysis of data concerning 498 lung cancer patients, including surgical and non-surgical cases, there is a clear association between higher tumour uptake of glucose and worse survival.
International Journal of Radiation Oncology*Biology*PhysicsIndividualized Radical Radiotherapy of Non–Small-Cell Lung Cancer Based on Normal Tissue Dose Constraints: A Feasibility Study
67 Citations2008Angela van Baardwijk, Geert Bosmans +10 more
Individualized maximal tolerable dose irradiation based on normal tissue dose constraints is feasible, and initial results are promising.
Critical Reviews in Oncology/HematologyGenomics and proteomics: Emerging technologies in clinical cancer research
67 Citations2006Christine H. Chung, Shawn Levy +2 more
The available technologies and associated bioinformatics are summarized, studies that are clinically relevant, and a framework for future directions of these technologies and how they should be applied in clinical studies are presented.
International Journal of Radiation Oncology*Biology*PhysicsHigh Radiation Dose May Reduce the Negative Effect of Large Gross Tumor Volume in Patients With Medically Inoperable Early-Stage Non–Small Cell Lung Cancer
65 Citations2007Lujun Zhao, Brady T. West +4 more
High-dose radiation is more important for patients with larger tumors and may be effective in reducing the adverse outcome associated with large GTV, and further prospective studies are needed to confirm this finding.
Journal of Cancer Research and Clinical OncologyA practical prognostic index for inoperable non-small-cell lung cancer
56 Citations1997Tuija Wigren, Hanna Oksanen +1 more
The prognostic factors were so strong that multivariate analyses did not reveal the treatment selection to have any significant influence on survival, and each of the five variables has the advantage of being routinely available, and is simple enough to be used in daily clinical practice.
Radiotherapy and OncologyConfirmation of a prognostic index for patients with inoperable non-small cell lung cancer
54 Citations1997Tuija Wigren
The prognostic index derived from a group of 502 patients with inoperable stages I-IIIb non-small cell lung cancer from 1974 to 1981 is verified and can easily be used to guide management in daily clinical practice.
Clinical Lung CancerPrognostic Factors in Stage III Non–Small-Cell Lung Cancer
52 Citations2007Foluso O. Ademuyiwa, Cynthia S. Johnson +5 more
This analysis suggests that FEV(1) > 2 L and higher pretreatment Hb values are associated with improved OS in patients with stage III NSCLC.
Radiotherapy and OncologyReferral rates and trends in radiotherapy as part of primary treatment of cancer in South Netherlands, 1988–2002
47 Citations2006Ans Vulto, Marieke W.J. Louwman +2 more
The percentage of cancer patients who received primary RT remained stable throughout 1988-2002, being consistently lower for older patients, and the increased number of irradiated patients was due mainly to earlier detection and the ageing of the population.
Journal of Thoracic OncologyWeighing Tumor Biology in Treatment Decisions for Patients with Non-small Cell Lung Cancer
40 Citations2007Frances A. Shepherd, Rafael Rosell
Although EGFR mutations are predictive of response to EGFR tyrosine kinase inhibitor (TKI) therapy, they do not appear to be predictive of a differential effect on survival, and other EGFR markers, such as protein expression or gene amplification, may be better predictors of a survival benefit from EGFR TKI.
Seminars in Surgical OncologyPrognostic factors in non‐small cell lung cancer
36 Citations2003Merrill J. Solan, Maria Werner‐Wasik
The purpose of this work is to review the modern literature with regard to prognostic factors for patients with non-small-cell lung cancer taking into account ongoing advances in clinical evaluation, staging, surgery, radiation therapy, chemotherapy, and molecular biology in this widely heterogeneous patient population.
Cancer SciencePrognostic models in patients with non‐small‐cell lung cancer using artificial neural networks in comparison with logistic regression
35 Citations2003Taizo Hanai, Yasushi Yatabe +5 more
It is demonstrated that ANN is a potentially more useful tool than conventional statistical methods for predicting survival of patients with NSCLC and that inclusion of relevant molecular markers as input variables enhances its predictive ability.
International Journal of Radiation Oncology*Biology*PhysicsFailure of T stage to predict survival in patients with non-small-cell lung cancer treated by radiotherapy with or without concomitant chemotherapy
25 Citations2002D. Ball, Jennifer Smith +2 more
There is some evidence that T stage is an independent prognostic factor in patients with NSCLC treated surgically, but it did not appear to be of value in this series of patients treated with RT with and without concomitant chemotherapy.